期刊文献+

肾动脉狭窄的治疗现状 被引量:9

The Current Therapeutic Status of Renal Artery Stenosis
下载PDF
导出
摘要 肾动脉狭窄与进行性缺血性肾衰竭和高血压相关的心血管疾病的发病率和死亡率有着密切关系。对于此类患者的治疗现在并无确定方法。现比较各种治疗的临床研究结果。内科药物治疗是各种治疗的基础,而且仍有进一步研究的空间。目前的资料显示腔内治疗相比外科和单纯内科治疗有一定的优势,但一些特殊的病例,外科治疗仍然是很好的选择。介入治疗中一些新技术,如肾动脉远端保护装置及药物涂层支架在临床应用已有尝试,但仍处于探索阶段。目前仍需大样本多中心随机对照试验来进一步明确证明介入治疗的作用。 Renal artery stenosis is associated with morbidity and mortality consequent to progressive ischemic renal failure and the cardiovascular consequences of hypertension. There is considerable uncertainty concerning the optimal management of affected patients. This review compares the results of clinical studies. Medical therapy is the main method used. Comparing medical and surgical therapies, current data shows that there is certain predominance given to interventional therapy. Surgery is still seen as a good option. Although still the subject of research, some new techniques and instruments for interventional therapy, such as a distal protection device and drug-eluting stent, have already been used in clinic, although. The results of larger, muhicentre, randomised, controlled trials are required to clarify and support intcrvcntional therapy in renal artery stenosis patients.
出处 《心血管病学进展》 CAS 2007年第1期10-12,共3页 Advances in Cardiovascular Diseases
关键词 肾动脉狭窄 治疗 renal artery stenosis therapy
  • 相关文献

参考文献23

  • 1Greco BA,Breyer JA.The natural history of renal artery stenosis:Who should be evaluated for suspected ischemic nephropathy[J]? Semin Nephrol,1996,16(1):2-11. 被引量:1
  • 2Cherr GS,Hansen KJ,Craven TEM,et al.Surgical management of atherosclerotic renovascular disease[J].J Vasc Surg,2002,35(2):236-245. 被引量:1
  • 3Hansen KJ.Prevalence of ischemic nephropathy in the atherosclerotic population[J].Am J Kidney Dis,1994,24(4):615-621. 被引量:1
  • 4Pillay WR,Kan YM,Crinnion JN,et al.Prospective multicentre study of the natural history of atherosclerotic renal artery stenosis in patients with peripheral vascular disease[J].Br J Surg,2002,89(6):737-740. 被引量:1
  • 5Iglesias JI,Hamburger RJ,Feldman L,et al.The natural history of incidental renal artery stenosis in patients with aortoiliac vascular disease[J].Am J Med,2000,109(8):642-647. 被引量:1
  • 6Conlon PJ,Athirakul K,Kovalik E,et al.Survival in renal vascular disease[J].J Am Soc Nephrol,1998,9(2):252-256. 被引量:1
  • 7Cambria RP,Brewster D,Lttlaien B,et al.The durability of different reconstructive techniques for atherosclerotic renal artery disease[J].J Vasc Surg,1994,20 (1):76-85. 被引量:1
  • 8Olin JW,Begelman SM.Renal artery disease.In:TOPOL E,ed.Textbook of cardiovascular medicine[M].2nd ed Philadelphia:Lippincott Raven,2002.2139-2159. 被引量:1
  • 9Haller C.Atherosclerotic renal artery stenosis:Conservative versus interventional management[J].Heart,2002,88(2):193-197. 被引量:1
  • 10Waters DD,LaRosa JC,Barter P,et al.Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (Treating to New Targets) Study[J].JACC,2006,48(9):1793-1799. 被引量:1

二级参考文献5

  • 1SCHAEFFNER ES,KURTH T,CURHAN GC,et al.Cholesterol and the risk of renal dysfunction in apparently healthy men[J].J Am Soc Nephrol,2003,14(8):2084-2091. 被引量:1
  • 2YAMASHITA T,KAWAHSIM S,MIWA Y,et al.A 3-hydroxy-3-methylglutaryl co-enzyme A reductase inhibitor reduces hypertensive nephrosclerosis in stroke-prone spontaneously hypertensive rats[J].J Hypertens,2002,20 (12):2465 -2473. 被引量:1
  • 3DAVIGNON J,LAAKSONEN R.Low-density lipoproteinindependent effects of statins[J].Curr Opin Lipidol,1999,10(6):543-559. 被引量:1
  • 4MOORHEAD JF.Lipids and progressive renal disease[J].Kidney Int,1991,31:S35-S40. 被引量:1
  • 5YOKOTA N,O' DONNELL M,DANIELS F,et al.Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury[J].Am J Nephrol,2003,23 (1):13-17. 被引量:1

共引文献2

同被引文献84

引证文献9

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部